38 results on '"De Masson A"'
Search Results
2. Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas
3. Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms
4. CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
5. CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas
6. Exploring the Nonlymphocytic Cutaneous Microenvironment in Advanced Cutaneous T-Cell Lymphomas using Single-Cell RNA Sequencing
7. Tumor Clone Frequency Calculation Using High-Throughput Sequencing of the TCRβ Gene in Patients with Folliculotropic Mycosis Fungoides
8. Male sex, discoid lupus erythematosus, and lower limb involvement are associated with systemic lupus in lupus panniculitis patients: A multicenter case series of 74 patients
9. CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
10. RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea
11. Involvement of the CD39/CD73/adenosine pathway in T-cell proliferation and NK cell-mediated antibody-dependent cell cytotoxicity in Sézary syndrome
12. Clinical, pathological, and molecular features of myelodysplasia cutis
13. Increased CD8+CD28− circulating T cells and high blood interferon score characterize the systemic inflammation of amyopathic dermatomyositis
14. Expansion of Circulating CD49b+LAG3+ Type 1 Regulatory T Cells in Human Chronic Graft-Versus-Host Disease
15. Mogamulizumab for Refractory CD3-CD4+ Lymphocytic-Variant Hypereosinophilic Syndrome
16. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
17. MDA5+ Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ Transcript
18. Assessment of T-cell polarization on the basis of surface marker expression: Diagnosis and potential therapeutic implications in lymphocytic variant hypereosinophilic syndrome
19. Who Needs a Skin Exam? Skin Cancers in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Contemporary Era
20. 464 CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
21. 267 Characterization of Cancer-Associated Fibroblasts from Mycosis Fungoides and Sézary syndrome
22. Patient Characteristics of Long-Term Responders to Mogamulizumab: Results from the MAVORIC Study
23. Congenital yellow nail syndrome presenting with eyelid lymphedema and fetal hydrops
24. 465 Cutaneous T-cell lymphoma cells release proapoptotic Fas ligand in lysosomal secretory vesicles
25. 043 Persistent deficiency of mucosal associated invariant T cells in dermatomyositis
26. 019 Long-term clinical outcome and HAVCR2 mutations in 70 patients with subcutaneous panniculitis-like T-cell lymphoma: a study from the French Cutaneous Lymphoma Group
27. 1032 Glycolipid antigens presented by CD1 may drive T cell activation in cutaneous T cell lymphoma
28. 1015 Radiation therapy eradicates malignant T cells and is associated with improved survival in early-stage mycosis fungoides
29. 088 Skin delivery of modified vaccinia ankara (MVA) virus generates superior protective pulmonary immunity
30. Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation
31. Donor Lymphocyte Infusion for Primary Cutaneous T Cell Lymphomas: A Study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the French Study Group on Cutaneous Lymphomas (GFLEC)
32. Folliculotropic CD8+ mycosis fungoides associated with diffuse mucosal involvement
33. 458 CD8+ T cell skin infiltration predicts disease progression in CTCL patients
34. 110 Tumor clone frequency is a robust predictor of progression and survival in patients with Stage IB mycosis fungoides
35. 106 Early stage mycosis fungoides has a mutanome distinct from Sezary Syndrome
36. 056 Skin scarification with modified vaccinia ankara (MVA) virus generates protective pulmonary immunity
37. Brentuximab Vedotin Followed By Allogeneic Stem-Cell Transplantation for Patients with CD30 Anaplastic or T Cell Non Hodgkin Lymphomas: A Study on Behalf of the SFGM-TC.
38. Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.